Wydeheft , L. et al. 2026. GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients. Quality in Sport. 49, (Jan. 2026), 67673. DOI:https://doi.org/10.12775/QS.2026.49.67673.